An assisted living center for people with dementia has been fined $6,000 for a serious medication error that resulted in a ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...

A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...

Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nitrogen-containing bisphosphonates (NBPs), a ...

Research from UC Santa Cruz indicates that the P3 peptide—an alternative cleavage product of the amyloid precursor protein—may play a role in Alzheimer’s disease.

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...

A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications affect living human brains. This approach could replace invasive tests and ...

Nia Therapeutics' Smart Neurostimulation System (SNS) is the first device to obtain FDA breakthrough designation for memory ...

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...